Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Aims: To assess (1) how far the efficacies of front‐line smoking cessation pharmacotherapies vary as a function of smoker characteristics and (2) associations between these characteristics and success of smoking cessation attempts. Design: Prospective correlational study in the context of a double‐blind randomized trial. The outcome was regressed individually onto each covariate after adjusting for treatment, and then a forward stepwise model constructed. Treatment moderator effects of covariates were tested by treatment × covariate interactions. Setting: Health service facilities in multiple countries. Participants: Data came from 8120 smokers willing to make a quit attempt, randomized to varenicline, bupropion, nicotine replacement therapy (NRT) or placebo in Evaluating Adverse Events in a Global Smoking Cessation Study (EAGLES) between 30 November 2011 and 13 January 2015. Measurements: Smoker characteristics measured at baseline were country, psychiatric history, sex, age, body mass index (BMI), ethnic group, life‐time suicidal ideation/behaviour, anxiety, depression, aggression, psychotropic medication, history of alcohol/substance use disorder, age of starting smoking, cigarette dependence [Fagerström Test for Cigarette Dependence (FTCD)] and prior use of study medicines. Outcome was biochemically confirmed continuous abstinence at weeks 9–24 from start of treatment. Findings: No statistically significant treatment × covariate interactions were found. Odds of success were associated independently positively with age [odds ratio (OR) = 1.01; 95% confidence interval (CI) = 1.00, 1.01], BMI (1.01; 95% CI = 1.00, 1.02) and age of starting smoking (1.03; 95% CI = 1.02, 1.04). Odds were associated independently negatively with US (versus non‐US) study site (0.53; 95% CI = 0.46, 0.61), black (versus white) ethnic group (0.57; 95% CI = 0.45, 0.72), mood disorder (0.85; 95% CI = 0.73, 0.99), anxiety disorder (0.71; 95% CI = 0.55, 0.90) and psychotic disorder (0.73; 95% CI = 0.50, 1.07), taking psychotropic medication (0.81; 95% CI = 0.68, 0.95), FTCD (0.89; 95% CI = 0.87, 0.92) and previous use of NRT (0.78; 95% CI = 0.67, 0.91). Conclusions: While a range of smoker characteristics—including psychiatric history, cigarette dependence and prior use of nicotine replacement therapy (NRT)—are associated with lower cessation rates, they do not substantially influence the efficacy of varenicline, bupropion or NRT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111704 · Cited by 5,157
Buss, A. H., & Perry, M. (1992) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.63.3.452 · Cited by 4,693
Outcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285 · cited 1×
“We used weeks 9–24 (a period that includes the last 4 weeks of treatment and 12-week non-treatment follow-up) as this provided a measure that is closest to the Russell Standard, the recommended end-point to ensure greatest confidence in extrapolating to life-time abstinence [26].”
MethodSelf-citationAnthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Self-citationVangeli, E., Stapleton, J., Smit, E. S., Borland, R., & West, R. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03565.x · Cited by 607 · cited 2×
“This observation is in accordance with population-level studies [4], but is at variance with some clinical studies [16].”
BackgroundResultSelf-citationZhou, X., Nonnemaker, J., Sherrill, B., Gilsenan, A. W., Coste, F., & West, R. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.11.013 · Cited by 508
Self-citationRelapse and maintenance issues for smoking cessation
Ockene, J. K., Mermelstein, R. J., Bonollo, D. S., Emmons, K. M., Perkins, K. A., Voorhees, C. C., & Hollis, J. F. (2000) · Health Psychology · doi:10.1037/0278-6133.19.suppl1.17 · Cited by 337
Past major depression and smoking cessation outcome: A systematic review and meta-analysis update
Hitsman, B., Papandonatos, G. D., McChargue, D. E., DeMott, A., Herrera, M. J., Spring, B., Borrelli, B., & Niaura, R. (2013) · Addiction · doi:10.1111/add.12009 · Cited by 162 · cited 1×
“There is less consistent, conflicting or negative evidence on the effects of age of smoking onset [2,3], substance use disorder [8], psychiatric disorder [6,9], gender [4,6,10], geographical location [11,12], body mass index (BMI) [2,3,10,13,14] and prior use of smoking cessation treatments [15].”
BackgroundKulak, J. A., Cornelius, M. E., Fong, G. T., & Giovino, G. A. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv228 · Cited by 124
Cited by
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Antidepressants for smoking cessation
Hajizadeh, A., Howes, S., Theodoulou, A., Klemperer, E., Hartmann-Boyce, J., Livingstone-Banks, J., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub6 · Cited by 84
Nollen, N. L., Mayo, M. S., Sanderson Cox, L., Benowitz, N. L., Tyndale, R. F., Ellerbeck, E. F., Scheuermann, T. S., & Ahluwalia, J. S. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz001 · Cited by 62
Self-citationHeffner, J. L., Evins, A. E., Russ, C., Lawrence, D., Ayers, C. R., McRae, T., Aubin, L. S., Krishen, A., West, R., & Anthenelli, R. M. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.008 · Cited by 23
Self-citationLee, S. H., Yi, Y. H., Lee, Y. I., Lee, H. Y., & Lim, K.-M. (2022) · Medicine · doi:10.1097/md.0000000000029595 · Cited by 10
Metadata
- Authors
- West, R., Evins, A. E., Benowitz, N. L., Russ, C., McRae, T., Lawrence, D., St Aubin, L., Krishen, A., Maravic, M. C., & Anthenelli, R. M.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2018-03-30
- Volume
- 113
- Issue
- 8
- Pages
- 1507-1516
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2789290973
- Cited by
- 83
- References
- 9
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES. https://app.cochat.ai/papers/10.1111/add.14208
- The paper
- West, R., Evins, A. E., Benowitz, N. L., Russ, C., McRae, T., Lawrence, D., St Aubin, L., Krishen, A., Maravic, M. C., & Anthenelli, R. M. (2018). Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES. Addiction. https://doi.org/10.1111/add.14208
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.